GLP1R and type 2 diabetes mellitus: Similarly, a delayed-release preparation of the first-line drug for T2D, metformin was less bioavailable but as effective as “normal” metformin, suggesting an involvement of the distal bowel (ileum and colon) in its therapeutic efficacy, presumably via increased GLP-1 secretion from L cells and enhanced neural signaling (55).